Literature DB >> 3029113

Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein.

S Kassis, M Olasmaa, L Terenius, P H Fishman.   

Abstract

Neuropeptide Y, a major neuropeptide and potent vasoconstrictor, inhibited isoproterenol-stimulated adenylate cyclase activity in cultured rat atrial cells as well as in atrial membranes. Prior treatment of the cells with pertussis toxin blocked the inhibitory action of neuropeptide Y. Pertussis toxin is known to uncouple the receptors for other inhibitors of adenylate cyclase by ADP-ribosylation of the alpha-subunit of Gi, the inhibitory guanine nucleotide binding component of adenylate cyclase. The toxin specifically catalyzed the ADP-ribosylation of a 41-kilodalton atrial membrane protein which corresponded to the Gi subunit. These results suggest that neuropeptide Y may mediate some of its physiological effects through specific receptors linked to the inhibitory pathway of adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029113

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.

Authors:  P Valet; M Berlan; M Beauville; F Crampes; J L Montastruc; M Lafontan
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

2.  Neuropeptide Y (NPY) metabolism by endopeptidase-2 hinders characterization of NPY receptors in rat kidney.

Authors:  J S Price; A J Kenny; N S Huskisson; M J Brown
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  G-protein coupling and signalling of Y1-like neuropeptide Y receptors in SK-N-MC cells.

Authors:  F Feth; W Rascher; M C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

4.  Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.

Authors:  R Andriantsitohaina; J C Stoclet
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

5.  Neuropeptide Y antagonises secretagogue evoked chloride transport in rat jejunal epithelium.

Authors:  H M Cox; A W Cuthbert
Journal:  Pflugers Arch       Date:  1988-11       Impact factor: 3.657

6.  Peptide YY Y1 receptor activates mitogen-activated protein kinase and proliferation in gut epithelial cells via the epidermal growth factor receptor.

Authors:  P J Mannon; J M Mele
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

7.  pp60Src mediates insulin-stimulated sequestration of the beta(2)-adrenergic receptor: insulin stimulates pp60Src phosphorylation and activation.

Authors:  Elena Shumay; Xiaosong Song; Hsien-yu Wang; Craig C Malbon
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

8.  The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte.

Authors:  H M Piper; B C Millar; B J McDermott
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

9.  Effects of neuropeptide Y on L-type calcium current in guinea-pig ventricular myocytes.

Authors:  S M Bryant; G Hart
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  The effect of neuropeptide Y on sodium, chloride and potassium transport across the rat distal colon.

Authors:  D Strabel; M Diener
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.